Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a major subtype of non-small cell lung cancer (NSCLC) with a highly heterogeneous tumor microenvironment. Immune checkpoint inhibitors (ICIs) are more effective in tumors with a pre-activated immune status. However, the potential of the immune activation-ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Weibiao, Wang, Jin, Yang, Jian, Chen, Zhike, Cui, Yuan, Li, Qifan, Luo, Gaomeng, Ding, Hao, Ju, Sheng, Li, Baisong, Chen, Jun, Xie, Yufeng, Tong, Xin, Liu, Mi, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364982/
https://www.ncbi.nlm.nih.gov/pubmed/37492563
http://dx.doi.org/10.3389/fimmu.2023.1217590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364982/
https://www.ncbi.nlm.nih.gov/pubmed/37492563
http://dx.doi.org/10.3389/fimmu.2023.1217590

Ejemplares similares